IS4174A - Ný notkun á lyfjafræðilega viðurkenndu salti - Google Patents

Ný notkun á lyfjafræðilega viðurkenndu salti

Info

Publication number
IS4174A
IS4174A IS4174A IS4174A IS4174A IS 4174 A IS4174 A IS 4174A IS 4174 A IS4174 A IS 4174A IS 4174 A IS4174 A IS 4174A IS 4174 A IS4174 A IS 4174A
Authority
IS
Iceland
Prior art keywords
pharmaceutically acceptable
acceptable salt
pct
new use
sec
Prior art date
Application number
IS4174A
Other languages
English (en)
Icelandic (is)
Inventor
Torsten Eek Arne
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4174(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ab Astra filed Critical Ab Astra
Publication of IS4174A publication Critical patent/IS4174A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Air Conditioning Control Device (AREA)
  • Medicinal Preparation (AREA)
  • Particle Accelerators (AREA)
  • Electromechanical Clocks (AREA)
  • Steroid Compounds (AREA)
IS4174A 1993-06-28 1994-06-08 Ný notkun á lyfjafræðilega viðurkenndu salti IS4174A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
IS4174A true IS4174A (is) 1994-12-29

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4174A IS4174A (is) 1993-06-28 1994-06-08 Ný notkun á lyfjafræðilega viðurkenndu salti

Country Status (32)

Country Link
US (2) US5670524A (cg-RX-API-DMAC7.html)
EP (1) EP0706395B1 (cg-RX-API-DMAC7.html)
JP (1) JP3725541B2 (cg-RX-API-DMAC7.html)
CN (1) CN1074918C (cg-RX-API-DMAC7.html)
AT (1) ATE216237T1 (cg-RX-API-DMAC7.html)
BR (1) BR9406865A (cg-RX-API-DMAC7.html)
CA (1) CA2165446C (cg-RX-API-DMAC7.html)
CZ (1) CZ283300B6 (cg-RX-API-DMAC7.html)
DE (2) DE706395T1 (cg-RX-API-DMAC7.html)
DK (1) DK0706395T3 (cg-RX-API-DMAC7.html)
EE (1) EE03205B1 (cg-RX-API-DMAC7.html)
ES (1) ES2099048T3 (cg-RX-API-DMAC7.html)
FI (1) FI956269A7 (cg-RX-API-DMAC7.html)
GR (1) GR970300013T1 (cg-RX-API-DMAC7.html)
HU (1) HU218949B (cg-RX-API-DMAC7.html)
IL (1) IL110006A (cg-RX-API-DMAC7.html)
IS (1) IS4174A (cg-RX-API-DMAC7.html)
LT (1) LT3449B (cg-RX-API-DMAC7.html)
LV (1) LV12918B (cg-RX-API-DMAC7.html)
MY (1) MY119360A (cg-RX-API-DMAC7.html)
NO (1) NO955313L (cg-RX-API-DMAC7.html)
NZ (1) NZ268110A (cg-RX-API-DMAC7.html)
PH (1) PH31258A (cg-RX-API-DMAC7.html)
PL (1) PL175518B1 (cg-RX-API-DMAC7.html)
PT (1) PT706395E (cg-RX-API-DMAC7.html)
RU (1) RU2152215C1 (cg-RX-API-DMAC7.html)
SA (1) SA94150010B1 (cg-RX-API-DMAC7.html)
SE (1) SE9302218D0 (cg-RX-API-DMAC7.html)
SG (1) SG49078A1 (cg-RX-API-DMAC7.html)
SK (1) SK280111B6 (cg-RX-API-DMAC7.html)
TW (1) TW285640B (cg-RX-API-DMAC7.html)
WO (1) WO1995000148A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
BR9802536A (pt) * 1997-07-21 1999-07-20 Darwin Discovery Ltd Método para anestesiar um paciente humano antes de cirurgias
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
USRE46397E1 (en) 2007-11-07 2017-05-09 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
EP2882745A2 (en) * 2012-05-10 2015-06-17 Cellixbio Private Limited Compositions and methods for the treatment of local pain
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
WO2014134510A1 (en) 2013-02-28 2014-09-04 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60502054A (ja) * 1983-08-01 1985-11-28 アストラ・レケメデル・アクチボラグ L―N―n―プロピルピペコリン酸―2,6―キシリダイドおよびその製造方法
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
FI956269L (fi) 1995-12-27
PL175518B1 (pl) 1999-01-29
SK164695A3 (en) 1996-07-03
SK280111B6 (sk) 1999-08-06
HUT75115A (en) 1997-04-28
EP0706395B1 (en) 2002-04-17
LV12918B (en) 2003-03-20
GR970300013T1 (en) 1997-05-31
PT706395E (pt) 2002-09-30
FI956269A0 (fi) 1995-12-27
EE03205B1 (et) 1999-08-16
PL312198A1 (en) 1996-04-01
DE69430427T2 (de) 2002-11-14
NZ268110A (en) 1999-06-29
JP3725541B2 (ja) 2005-12-14
US5834489A (en) 1998-11-10
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
TW285640B (cg-RX-API-DMAC7.html) 1996-09-11
NO955313D0 (no) 1995-12-27
DE706395T1 (de) 1997-09-04
CZ283300B6 (cs) 1998-02-18
NO955313L (no) 1995-12-27
DE69430427D1 (de) 2002-05-23
HU218949B (hu) 2001-01-29
CA2165446C (en) 2005-07-05
IL110006A0 (en) 1994-11-11
MY119360A (en) 2005-05-31
LTIP1958A (en) 1995-01-31
IL110006A (en) 1999-01-26
SE9302218D0 (sv) 1993-06-28
US5670524A (en) 1997-09-23
CN1074918C (zh) 2001-11-21
SA94150010B1 (ar) 2006-04-04
BR9406865A (pt) 1996-03-26
AU7086694A (en) 1995-01-17
CN1126435A (zh) 1996-07-10
AU692161B2 (en) 1998-06-04
HK1010344A1 (en) 1999-06-17
RU2152215C1 (ru) 2000-07-10
ATE216237T1 (de) 2002-05-15
WO1995000148A1 (en) 1995-01-05
FI956269A7 (fi) 1995-12-27
ES2099048T1 (es) 1997-05-16
LT3449B (en) 1995-10-25
HU9503692D0 (en) 1996-02-28
CA2165446A1 (en) 1995-01-05
PH31258A (en) 1998-06-18
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
EP0706395A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
SE9401728D0 (sv) New compounds II
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
NO960630L (no) Heterocykler anvendelige som neurokinin antagonister
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
HU9503874D0 (en) New pharmaceutical formulation
IS4174A (is) Ný notkun á lyfjafræðilega viðurkenndu salti
IS4722A (is) Notkun 1-(2-naft-2-ýletýl)-4(3-tríflúorómetýlfenýl)-1,2,3,6-tetrahýdrópýridíns til gerðar lyfja tilþess að meðhöndla hliðarstrengjahersli
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
DE69518229D1 (de) Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
SE9504267D0 (sv) New therapeutic use
WO2000002877A3 (en) New pharmaceutically active compounds
SE9404438D0 (sv) New process
SE9401596D0 (sv) New compounds
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)